International Flavors & Fragrances IFF Pharma Solutions — CapEx
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by International Flavors & Fragrances in its filing.
Tagged under the XBRL concept us-gaap:SegmentExpenditureAdditionToLongLivedAssets.
The official record: International Flavors & Fragrances’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about International Flavors & Fragrances's pharma solutions — capex.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is International Flavors & Fragrances's pharma solutions — capex?
- International Flavors & Fragrances (IFF) reported pharma solutions — capex of $0 in Q1 2026.
- How has International Flavors & Fragrances's pharma solutions — capex changed year-over-year?
- International Flavors & Fragrances's pharma solutions — capex decreased by 100.0% year-over-year, from $28M to $0.
- What is the long-term trend for International Flavors & Fragrances's pharma solutions — capex?
- Over 4 years (2021 to 2025), International Flavors & Fragrances's pharma solutions — capex has grown at a 6.1% compound annual growth rate (CAGR), from $30M to $38M.
- What does pharma solutions — capex mean?
- Reflects the cash outflows for the acquisition or maintenance of long-term physical assets, such as manufacturing facilities and equipment, within the Pharma Solutions segment. This metric indicates the level of investment in future capacity and operational maintenance.